---
figid: PMC12035766__MCO2-6-e70194-g002
figtitle: Molecular hydrogen reducing intestinal I/R injury
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12035766
filename: MCO2-6-e70194-g002.jpg
figlink: /pmc/articles/PMC12035766/figure/F4/
number: F4
caption: Mechanisms of molecular hydrogen reducing intestinal I/R injury. During intestinal
  I/R injury, bacteria, endotoxin, and reactive oxygen species enter the circulatory
  system and activate NF‐κB expression, leading to increased levels of TF, p‐NF‐κ
  B p65, NLRP3, Caspase‐1, and inflammatory factors. Hydrogen inhibits TNF‐α while
  elevating TF levels. This inhibition prevents the deleterious cycle of the inflammatory
  cascade and coagulation system activation by blocking the NF‐κB signaling pathway
  and its downstream molecule NLRP3 inflammatory vesicle expression. Furthermore,
  hydrogen reduces intestinal I/R damage by upregulating the expression of IGF‐1,
  PI3K, AKT, and mTOR proteins and downregulating the expression of miR‐199a‐3p. In
  summary, hydrogen ameliorates intestinal I/R injury by suppressing the NF‐κB/NLRP3
  signaling pathway
papertitle: 'Molecular Hydrogen Therapy: Mechanisms, Delivery Methods, Preventive,
  and Therapeutic Application'
reftext: Jiayi Jin, et al. MedComm (2020). 2025 May;6(5).
year: '2025'
doi: 10.1002/mco2.70194
journal_title: MedComm
journal_nlm_ta: MedComm (2020)
publisher_name: Wiley
keywords: delivery methods | intestinal diseases | molecular hydrogen (H2) | mechanisms
  of action | nanoplatforms
automl_pathway: 0.9624523
figid_alias: PMC12035766__F4
figtype: Figure
redirect_from: /figures/PMC12035766__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12035766__MCO2-6-e70194-g002.html
  '@type': Dataset
  description: Mechanisms of molecular hydrogen reducing intestinal I/R injury. During
    intestinal I/R injury, bacteria, endotoxin, and reactive oxygen species enter
    the circulatory system and activate NF‐κB expression, leading to increased levels
    of TF, p‐NF‐κ B p65, NLRP3, Caspase‐1, and inflammatory factors. Hydrogen inhibits
    TNF‐α while elevating TF levels. This inhibition prevents the deleterious cycle
    of the inflammatory cascade and coagulation system activation by blocking the
    NF‐κB signaling pathway and its downstream molecule NLRP3 inflammatory vesicle
    expression. Furthermore, hydrogen reduces intestinal I/R damage by upregulating
    the expression of IGF‐1, PI3K, AKT, and mTOR proteins and downregulating the expression
    of miR‐199a‐3p. In summary, hydrogen ameliorates intestinal I/R injury by suppressing
    the NF‐κB/NLRP3 signaling pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TAM
  - STIM1
  - TLR1
  - TLR2
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR7
  - TLR8
  - TLR9
  - TLR10
  - MARK2
  - F2R
  - PWAR1
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - IRAK1
  - IRAK4
  - TAB2
  - TNFAIP3
  - IGKV1-27
  - IKBKG
  - MAP3K7
  - NR2C2
  - NFKB1
  - IL1A
  - IL1B
  - TF
  - GSDMD
  - PTEN
  - TNF
  - PDK1
  - PDPK1
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - RPTOR
  - Tyrosine
  - Pro-
  - TNF-a
---
